Monday, February 6, 2023

Corona vaccine gave Lonza a boost

by admin
0 comment

500 new jobs

Corona vaccine gave Lonza a boost

Lonza operates the largest biopharmaceutical production facility in Europe in Visp VS. In the current year alone, Lonza has invested around one billion francs in Visp, said Board Chairman Albert Baehni in an interview with the Tamedia newspapers.

The pharmaceutical company Lonza has significantly increased investments at the Visp VS site in recent years. (archive image)

In addition, Lonza is investing another half a billion francs in Stein in Aargau. In the last ten years, the company has doubled the number of employees in Visp to 5,000. In the current year alone, 500 new jobs have been added.

Lonza pays more than 400 million Swiss francs annually in wages and pension fund contributions in Visp and an average of more than 100 million Swiss francs to local third-party companies that the group needs to expand. The fact that Lonza hasn’t paid a profit tax in Valais for six years has sparked discussions in the canton.

Related News

Latest Switzerland News and updates and political news, follow our daily update about the congress and the government roundup, we also provide the latest news from all over the world minute by minute, subscribe to get the latest updates directly to your inbox.

© 2022 All Right Reserved. Switzerland Times